Access for rare diseases - how to navigate conflict, compromise and collaboration


Episode Artwork
1.0x
0% played 00:00 00:00
Jan 31 2022 35 mins  

World Orphan Drug Congress panel discussion November 2021

"Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists -

  • Karl Freemyer, Head of Business Development - FIECON (host)
  • Martin Schuchardt, Director of Pricing and Market Access - FIECON
  • Simon Eade, Vice president of Worldwide global strategy - Janssen
  • Oriol Sola-Morales, CEO of Health Innovation Technology Transfer
  • Eric Low, CEO - Eric Low Consulting